David Haskell
- Psychiatry and Mental health top 10%
- Pharmacology top 10%
- Clinical Psychology
- Experimental and Cognitive Psychology top 10%
- Physiology
- Co-authors
- Alberto DiMascioBrigitte A. PrusoffEugene S. PaykelG. GárdosDavid W. MarbyPatricia MooreJonathan ColeDouglas M. McNair
- Topics
- Treatment of Major Depression (4 papers)Schizophrenia research and treatment (4 papers)Attention Deficit Hyperactivity Disorder (3 papers)
- Partner nations
- United States
In The Last Decade
David Haskell
14 papers receiving 377 citations
Peers
Comparison fields: 5 of 74
- Psychiatry and Mental health 174
- Pharmacology 130
- Clinical Psychology 98
- Experimental and Cognitive Psychology 92
- Physiology 67
Countries citing papers authored by David Haskell
This map shows the geographic impact of David Haskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Haskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Haskell more than expected).
Fields of papers citing papers by David Haskell
This network shows the impact of papers produced by David Haskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Haskell. The network helps show where David Haskell may publish in the future.
Co-authorship network of co-authors of David Haskell
This figure shows the co-authorship network connecting the top 25 collaborators of David Haskell. A scholar is included among the top collaborators of David Haskell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Haskell. David Haskell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 64 | |
| 2 | 9 | |
| 3 | 51 | |
| 4 | A survey of diazepam patients. | 6 |
| 5 | 18 | |
| 6 | Doxepin or diazepam for anxious and anxious-depressed outpatients? | 18 |
| 7 | 5 | |
| 8 | 34 | |
| 9 | 99 | |
| 10 | 27 | |
| 11 | 4 | |
| 12 | 46 | |
| 13 | 19 | |
| 14 | 28 |
About David Haskell
David Haskell is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology, having authored 14 papers that have together received 428 indexed citations. Recurring topics across this work include Treatment of Major Depression (4 papers), Schizophrenia research and treatment (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). The work is most often cited by research in Aging (32 citations), Psychiatry and Mental health (174 citations) and Pharmacology (130 citations). David Haskell has collaborated with scholars based in United States. Frequent co-authors include Alberto DiMascio, Brigitte A. Prusoff, Eugene S. Paykel, G. Gárdos, David W. Marby, Patricia Moore, Jonathan Cole, Douglas M. McNair, Susan Paine and Gerald L. Klerman. Their work appears in journals such as JAMA, Psychological Medicine and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.